arrow
A

Andreas Boehm

irccs aviano (cro)
H指数:30
被引数:3,122

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reply to 'Comment on Toxicities in long-term survivors of head and neck cancer-A multi-national cross-sectional analysis'
2025-12-010
PRE
Unmet supportive care needs among head and neck cancer survivors beyond 5 years after diagnosis: a multinational cohort study

诊断5年后头颈癌幸存者中未满足的支持性照护需求:一项跨国队列研究

2025-10-160
OAAI
Toxicities in long-term survivors of head and neck cancer—A multi-national cross-sectional analysis

头颈癌长期幸存者的毒副作用——一项跨国横断面分析

2025-07-300
OAAI
UV1 vaccination in pembrolizumab-treated patients with recurrent or metastatic head and neck cancer: A randomized multicenter phase 2 trial

UV1疫苗接种在经帕博利珠单抗治疗、患有复发性或转移性头颈癌患者中的效果:一项随机多中心II期临床试验

Med
IF11.8
2025-04-110
PRE
The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important change
2024-11-010
PRE
Long-term health-related quality of life in head and neck cancer survivors: A large multinational study

头颈部癌症幸存者的长期健康相关生活质量: 一项大型跨国研究

2024-02-0511
OAAI
Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale

确定欧洲癌症研究和治疗组织头颈癌模块 (EORTC QLQ-HN43) 的最小重要差异和最小重要变化分数的方法学方法,以吞咽量表为例

2021-07-1611
OAAI
Obtaining Patient-Reported Outcomes Electronically With OncoFunction in Head and Neck Cancer Patients During Aftercare

在后期护理期间通过电子方式获得具有OncoFunction功能的患者报告的结果

2020-11-2512
OAAI
Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II

诱导化疗 (IC) 后放疗 (RT) 与西妥昔单抗加IC和RT治疗只能通过全喉切除术切除的晚期喉癌/下咽癌-喉器官保存试验delos-ii的最终结果

2018-10-0156
OAAI
Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma
2017-04-0498
OAAI
Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one cycle induction chemotherapy by a score based on clinical evaluation, computed tomography-based volumetry and 18F-FDG-PET/CT
2017-02-0128
PREAI
The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer
2015-07-06193
OA